Álvaro Cabrera García

Álvaro Cabrera García

Auto-generated profile, based on publicly available information

Álvaro Cabrera García

Department of Hematology, Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, State of Mexico, Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2019 in Memoria. Investigaciones en Ingenieria
Verified
Journal Article
Open access
PDF file
DJDaniel Jurburg
Daniel Jurburg
ACAlvaro Cabrera
Alvaro Cabrera
En paralelo con los desafíos técnicos relacionados a la Industria 4.0, un nuevo reto surge: ¿cómo preparar a los actuales y futuros trabajadores, de manera de que puedan adaptarse a los empleos que surgirán y que demandarán nuevos requisitos en términos de competencias? El objetivo principal de este proyecto es investigar qué competencias serán esenciales para el futuro del sector agroindustrial. Se enfoca el estudio en dicho sector dado que este es uno de los sectores económicos con mayor riesgo de automatización de los puestos de trabajo según la literatura. Para determinar las competencias necesarias, se realizó una extensa revisión de la literatura, de la que surgieron 31 competencias consideradas fundamentales para el futuro. Dicha matriz de competencias fue luego validada a través de la realización de una serie de entrevistas semi-estructuradas a stakeholders del sector, para determinar los niveles actuales en materia de esas 31 competencias, y su ponderación para el futuro. En particular, se generaron gráficos de radar mostrando los valores actuales y futuros, identificando el gap de competencias necesario para avanzar en materia de transformación digital y tecnológica del sector. Las competencias determinadas como las más relevantes para el futuro son: Conocimientos de Informática, Capacidad de operar con nuevas interfaces, Aprendizaje Continuo, Pensamiento Analítico y Lógico, Expresión Oral, Trabajo en equipo, Confianza en la tecnología y Flexibilidad

14 January 2025 in Blood Research
Verified
Journal Article
Open access
PDF file
CPChristian Omar Ramos Peñafiel
Christian Omar Ramos Peñafiel
DSDaniela Pérez Sámano
Daniela Pérez Sámano
ARAdan German Gallardo Rodriguez
Adan German Gallardo Rodriguez
CPCamila Terreros Palacio
Camila Terreros Palacio
IOIrma Olarte
Irma Olarte
ATADOLFO MARTINEZ TOVAR
ADOLFO MARTINEZ TOVAR
Purpose: Despite advances in the treatment of adult acute lymphoblastic leukemia (ALL), relapse remains the most significant challenge in improving prognosis. Measurable residual disease (MRD) assessment can predict bone marrow relapse based on MRD positivity. As access to innovative therapies remains limited because of the high cost, chemotherapy is the widely utilized treatment option. The efficacy of a combination of bortezomib and Hyper-CVAD has been reported in patients with multiple myeloma; however, its efficacy has not yet been confirmed in patients with ALL. Methods: This prospective cohort study involved patients with ALL who presented with MRD-positive results or relapse and received treatment with a combination of bortezomib and Hyper-CVAD at two reference centers in Mexico City. Results: Of the 20 patients with positive MRD included in this study, 60% (n = 12) exhibited MRD negative results after combination treatment, 30% (n = 6) persisted positive MRD results, and 10% (n = 2) passed away. Of the 23 patients with bone marrow relapse, 43.5% (n = 10) achieved a second complete remission (2CR), 34.8% (n = 6) exhibited refractory status, and 21.7% (n = 5) passed away. To achieve a 2CR, 20% (n = 2) patients required less than four cycles of treatment, 50% (n = 5) required four cycles (two A and B cycles each), and 30% (n = 3) required six cycles. Conclusion: The combination of bortezomib and Hyper-CVAD treatment exhibited better results in achieving MRD negative results, indicating its potential as a promising first-line treatment strategy for ALL.

17 April 2026 in JMIR Cancer
Verified
Journal Article
Open access
CPChristian Omar Ramos Peñafiel
Christian Omar Ramos Peñafiel
ÁGÁlvaro Cabrera García
Álvaro Cabrera García
CDCarolina Balderas Delgado
Carolina Balderas Delgado
RTRocío Luna Tentle
Rocío Luna Tentle
ASAndrea Iracema Milán salvatierra
Andrea Iracema Milán salvatierra
ARAdan German Gallardo Rodriguez
Adan German Gallardo Rodriguez
Background: Electronic medical record (EMR) systems have been associated with better clinical workflows and fewer documentation errors. However, evidence regarding their effect on time-sensitive leukemia care in public hospitals in Latin America remains limited. Objective: This study aimed to compare 60-day mortality and urgent supportive-care processes between 2 tertiary public hospitals in Mexico with different documentation models (integrated EMR vs traditional physical records [TPR]), under the hypothesis that digital workflows may facilitate more timely treatment. Methods: We conducted a retrospective natural experiment including 274 patients with newly diagnosed acute leukemia treated between February 2023 and April 2025. Clinical characteristics, treatment intensity, complications during induction, antibiotic administration times, and survival outcomes were abstracted from finalized institutional records that are routinely reviewed at discharge by the institutional medical record committee as part of standard quality-assurance procedures. The primary outcome was 60-day mortality. Secondary outcomes included time to first antibiotic dose after recognition of febrile neutropenia, treatment-related complications, and the number of operational steps required for urgent care processes. A subgroup analysis of 70 patients with complete timing documentation was performed for antibiotic administration. Comparisons between hospitals were performed using univariate tests, Kaplan-Meier 60-day survival curves, and multivariable logistic regression. Results: Of the 274 included patients, 104 (38%) were treated at the hospital using an integrated EMR, and 170 (62%) at the hospital using TPR. Sixty-day mortality was lower in the EMR hospital (6/104, 5.8%) than in the TPR hospital (61/170, 35.9%; P<.001). In the subgroup with complete timing data, the mean time from febrile episode recognition to first antibiotic administration was shorter in the hospital using EMR than in the hospital using TPR (54, SD 18.4 minutes; P<.001). Although the EMR hospital used a higher proportion of high-intensity regimens, patients in that hospital had better 60-day outcomes. In multivariable analysis, hospital type remained independently associated with 60-day mortality (odds ratio 0.11, 95% CI 0.05-0.26; P<.001), whereas kidney injury and hepatotoxicity were associated with worse outcomes. Conclusions: In this natural experiment, the hospital using an integrated EMR had a lower 60-day mortality and shorter time to antibiotic administration than the hospital using TPR. These findings are hypothesis-generating and suggest that digital workflows may contribute to more timely urgent supportive care, but they should be interpreted with caution, given the retrospective 2-center design and the potential for residual confounding.

14 January 2025 in JMIR Preprints
Verified
Preprint
Open access
CPChristian Omar Ramos Peñafiel
Christian Omar Ramos Peñafiel
ÁGÁlvaro Cabrera García
Álvaro Cabrera García
CDCarolina Balderas Delgado
Carolina Balderas Delgado
RTRocío Luna Tentle
Rocío Luna Tentle
ASAndrea Iracema Milán salvatierra
Andrea Iracema Milán salvatierra
ARAdan German Gallardo Rodriguez
Adan German Gallardo Rodriguez
BACKGROUND Electronic medical record (EMR) systems have been associated with better clinical workflows and fewer documentation errors. However, evidence regarding their effect on time-sensitive leukemia care in public hospitals in Latin America remains limited. OBJECTIVE This study aimed to compare 60-day mortality and urgent supportive-care processes between 2 tertiary public hospitals in Mexico with different documentation models (integrated EMR vs traditional physical records [TPR]), under the hypothesis that digital workflows may facilitate more timely treatment. METHODS We conducted a retrospective natural experiment including 274 patients with newly diagnosed acute leukemia treated between February 2023 and April 2025. Clinical characteristics, treatment intensity, complications during induction, antibiotic administration times, and survival outcomes were abstracted from finalized institutional records that are routinely reviewed at discharge by the institutional medical record committee as part of standard quality-assurance procedures. The primary outcome was 60-day mortality. Secondary outcomes included time to first antibiotic dose after recognition of febrile neutropenia, treatment-related complications, and the number of operational steps required for urgent care processes. A subgroup analysis of 70 patients with complete timing documentation was performed for antibiotic administration. Comparisons between hospitals were performed using univariate tests, Kaplan-Meier 60-day survival curves, and multivariable logistic regression. RESULTS Of the 274 included patients, 104 (38%) were treated at the hospital using an integrated EMR, and 170 (62%) at the hospital using TPR. Sixty-day mortality was lower in the EMR hospital (6/104, 5.8%) than in the TPR hospital (61/170, 35.9%; P<.001). In the subgroup with complete timing data, the mean time from febrile episode recognition to first antibiotic administration was shorter in the hospital using EMR than in the hospital using TPR (54, SD 18.4 minutes; P<.001). Although the EMR hospital used a higher proportion of high-intensity regimens, patients in that hospital had better 60-day outcomes. In multivariable analysis, hospital type remained independently associated with 60-day mortality (odds ratio 0.11, 95% CI 0.05-0.26; P<.001), whereas kidney injury and hepatotoxicity were associated with worse outcomes. CONCLUSIONS In this natural experiment, the hospital using an integrated EMR had a lower 60-day mortality and shorter time to antibiotic administration than the hospital using TPR. These findings are hypothesis-generating and suggest that digital workflows may contribute to more timely urgent supportive care, but they should be interpreted with caution, given the retrospective 2-center design and the potential for residual confounding.